Why You Lose Fast-Twitch Muscle First (and What It Costs You)

Written by the Nuvirox Research Team

Short answer: because aging attacks fast-twitch fibers specifically, and those are the fibers that produce speed. The muscle you lose between 30 and 60 is not a proportional slice off the whole. Type I fibers, the slow endurance ones, hold their size remarkably well. Type II fibers, the fast powerful ones, shrink substantially. The functional consequence is that you can still carry the shopping but you can no longer sprint for the bus — and that asymmetry is measurable in muscle biopsies.

Schematic of fiber-type-specific atrophy. Circle sizes illustrate the reported direction and rough magnitude of cross-sectional area differences rather than measured values.

What are fiber types, in plain terms?

Two broad families of muscle cell, distinguished by how fast they contract and how they make energy. Type I fibers contract slowly, resist fatigue, and are densely packed with mitochondria — they run on oxygen and they run for a long time. Type II fibers contract quickly, produce far more force per unit time, fatigue rapidly, and rely more heavily on anaerobic pathways.

Every muscle contains a mix, and the proportion varies by muscle and by person. Postural muscles skew type I; the quadriceps carry a high proportion of type II, which is part of why lower-limb function declines so visibly with age. The mitochondrial density difference is also why fiber type intersects with everything in how mitochondrial content varies between tissues.

What human studies actually show

The foundational study examined whole muscles, not biopsy samples. Lexell and colleagues prepared cross-sections of autopsied whole vastus lateralis muscle from 43 previously healthy men aged 15 to 83. Because they had the entire muscle rather than a small sample, they could count total fiber number rather than estimate it. They reported that aging atrophy of this muscle begins around age 25 and accelerates thereafter, caused mainly by loss of fibers with no strong preference by type, and to a lesser extent by reduction in fiber size that fell predominantly on type II.

Later work put more weight on type II shrinkage than on fiber loss. Nilwik and colleagues reported that the decline in muscle mass with aging is mainly attributable to reduced type II fiber size, with 10–40% smaller type II fibers in tissue from older compared with young controls, while type I fiber size appeared largely unaffected across multiple studies. This is the finding that explains the functional pattern most people actually notice.

The pattern holds in clinically sarcopenic populations. A study of vastus lateralis biopsies from 32 patients with hip fracture, mean age 82, examined fiber morphology against formal sarcopenia criteria and found type II fiber atrophy associated with sarcopenia status. Since type II fibers are what produce rapid force, and rapid force is what arrests a stumble, the connection between this histology and fracture risk is not hypothetical.

The honest counterweight: the field genuinely disagrees about fiber loss versus fiber shrinkage. Lexell’s whole-muscle work attributed most atrophy to losing fibers outright; Nilwik’s analysis attributed it mainly to type II fibers getting smaller. Other work has suggested the difference in muscle size between old and young is due in roughly equal proportions to lower type II fiber cross-sectional area and to having fewer fibers. Evidence for fiber number decline rests on excised human muscle and on animal models with inconsistent findings, because you cannot count the fibers in a living person’s muscle. Anyone stating this confidently in one direction is overstating the literature.

Why does losing fast-twitch fiber matter more than it sounds?

Because power, not strength, is what everyday emergencies require. Strength is how much force you can produce given unlimited time. Power is force produced quickly. Getting out of a low chair, recovering from a trip on a kerb, and catching a falling object are all power tasks with a time limit measured in fractions of a second.

This is why someone can hold a respectable one-rep maximum while being unable to jump, and why rate-of-force-development declines faster with age than peak force does. It is also why grip strength predicts outcomes so consistently: it is a cheap proxy for the state of the whole system.

The other consequence is metabolic. Type II fibers are large contributors to glucose disposal and to overall lean mass, so their shrinkage removes metabolically active tissue. That connects directly to what we covered in whether metabolism actually slows with age: energy expenditure per unit of lean mass holds steady, but the amount of lean mass does not.

What this framing won’t explain

It will not explain rapid weakness, one-sided weakness, or weakness with other symptoms. Fiber-type atrophy is a decades-long process. Strength or power that fell away over weeks or months, weakness affecting one limb or one side, or weakness accompanied by numbness, pain, unexplained weight loss or difficulty swallowing are not this. Those warrant medical assessment rather than a training plan.

It also will not tell you your personal fiber composition. Muscle biopsy is the only reliable method, and consumer genetic tests marketed as revealing whether you are a ‘sprinter’ or an ‘endurance’ type explain only a small fraction of the variance. How you respond to training is a better guide than any test you can buy.

What actually defends type II fiber?

Loading that recruits it — which means either heavy or fast, not merely long. Motor units are recruited in order of size, from smallest and slowest to largest and fastest. Low-force activity never reaches the high-threshold units that contain type II fibers, which is why decades of walking do not preserve them. Resistance training with meaningful load, or deliberately fast movement against moderate load, does reach them.

Protein intake matters alongside the stimulus, because the muscle-building response to a given amount of protein becomes less efficient with age — a phenomenon usually described as anabolic resistance. We covered that in what happens when protein intake runs low. Training without adequate protein and protein without training both underperform the combination. For the aerobic side of the same question, our piece on zone 2 training and mitochondria covers why intensity keeps showing up in this literature.

Frequently asked questions

At what age does this start?

The whole-muscle data suggested atrophy of the vastus lateralis begins around age 25 and accelerates from there. That is far earlier than most people expect, though the early rate is slow enough to go unnoticed for a long time.

Can you convert type I fibers into type II?

Not meaningfully in the sense people usually mean. Training can shift fibers along a spectrum within the type II family, and can substantially change the size and metabolic properties of existing fibers, but wholesale conversion between the major types is not something training reliably achieves.

Is it too late to start lifting at 60 or 70?

No. Resistance training produces measurable hypertrophy and strength gains in older adults, including in the type II fibers that atrophied. Starting later means starting from a lower baseline, not being unable to adapt.

Does cardio make the problem worse?

It does not cause type II atrophy, but it also does nothing to prevent it. The risk is opportunity cost — a training week made entirely of steady aerobic work leaves the most vulnerable tissue unaddressed.

Why do my legs feel weaker than my arms as I age?

Partly because the quadriceps carry a high proportion of type II fibers, and partly because lower-limb muscles lose more mass overall. Declines in thigh cross-sectional area over the lifespan have been reported in the range of 25–40%.

From Nuvirox

Why we formulated NAD+ Restore

Nothing in a capsule rebuilds fast-twitch muscle — loading does that, and protein supports it. What we can reasonably address is the cellular energy machinery those fibers depend on, using an ingredient with published human pharmacokinetics rather than an aspirational blend.

• 500 mg Nicotinamide Riboside Chloride (NR) — one of the two most-researched NAD+ precursors, within the dose range used in published human trials.
• 150 mg trans-resveratrol (Japanese Knotweed) and 50 mg quercetin (Sophora japonica) — polyphenols studied alongside NAD+ pathways for cellular health support.
• 10 mg galactomannans from fenugreek — to support absorption.
• 60-day money-back guarantee — long enough to actually evaluate it the way the research says you should.

Learn more about NAD+ Restore →

The bottom line

Aging muscle does not shrink evenly, and the unevenness is the whole story. Type II fibers — the fast, powerful, metabolically expensive ones — take a reported 10–40% reduction in size while type I fibers hold close to their young dimensions. That is why power disappears before strength, why stumbles become falls, and why lean mass declines even when body weight doesn’t. The literature still argues about how much of the loss is fewer fibers versus smaller ones. It does not argue about which fiber type is losing.

References

1. Lexell J, Taylor CC, Sjöström M. What is the cause of the ageing atrophy? Total number, size and proportion of different fiber types studied in whole vastus lateralis muscle from 15- to 83-year-old men. Journal of the Neurological Sciences. 1988;84(2–3):275–294.
2. Nilwik R, Snijders T, Leenders M, et al. The decline in skeletal muscle mass with aging is mainly attributed to a reduction in type II muscle fiber size. Experimental Gerontology. 2013;48(5):492–498. DOI: 10.1016/j.exger.2013.02.012.
3. Tanganelli F, Meinke P, Hofmeister F, et al. Type-2 muscle fiber atrophy is associated with sarcopenia in elderly men with hip fracture. Experimental Gerontology. 2021;144:111171. PMID: 33248151.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This article is for informational purposes only and is not a substitute for professional medical advice.